- Home
- SNTI vs CLRO Comparison
SNTI vs CLRO Comparison
Compare SNTI & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- CLRO
- Stock Information
- Founded
- SNTI 2016
- CLRO 1983
- Country
- SNTI United States
- CLRO United States
- Employees
- SNTI N/A
- CLRO N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- SNTI Health Care
- CLRO Technology
- Exchange
- SNTI Nasdaq
- CLRO Nasdaq
- Market Cap
- SNTI 14.1M
- CLRO 13.9M
- IPO Year
- SNTI N/A
- CLRO N/A
- Fundamental
- Price
- SNTI $2.19
- CLRO $0.59
- Analyst Decision
- SNTI
- CLRO
- Analyst Count
- SNTI 0
- CLRO 0
- Target Price
- SNTI N/A
- CLRO N/A
- AVG Volume (30 Days)
- SNTI 23.2K
- CLRO 17.2K
- Earning Date
- SNTI 11-11-2024
- CLRO 11-07-2024
- Dividend Yield
- SNTI N/A
- CLRO 82.64%
- EPS Growth
- SNTI N/A
- CLRO N/A
- EPS
- SNTI N/A
- CLRO N/A
- Revenue
- SNTI $338,000.00
- CLRO $14,969,000.00
- Revenue This Year
- SNTI $254.47
- CLRO N/A
- Revenue Next Year
- SNTI $169.66
- CLRO N/A
- P/E Ratio
- SNTI N/A
- CLRO N/A
- Revenue Growth
- SNTI N/A
- CLRO N/A
- 52 Week Low
- SNTI $1.52
- CLRO $0.53
- 52 Week High
- SNTI $8.48
- CLRO $2.48
- Technical
- Relative Strength Index (RSI)
- SNTI 39.08
- CLRO 45.82
- Support Level
- SNTI $2.08
- CLRO $0.56
- Resistance Level
- SNTI $2.56
- CLRO $0.64
- Average True Range (ATR)
- SNTI 0.24
- CLRO 0.03
- MACD
- SNTI -0.04
- CLRO -0.00
- Stochastic Oscillator
- SNTI 10.57
- CLRO 31.25
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.